CD38 expression has no prognostic influence after autologous stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL)

被引:0
|
作者
Schloe, U
Viehmann, K
Lange, A
Ritgen, M
Dreger, P
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P631
引用
收藏
页码:S165 / S165
页数:1
相关论文
共 50 条
  • [1] Stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL):: Outcome and prognostic factors after autologous and allogeneic transplants.
    Esteve, J
    Montserrat, E
    Dreger, P
    Meloni, G
    Pavletic, S
    Catovsky, D
    Dearden, C
    Scimè, R
    Sutton, L
    Michallet, M
    Desablens, B
    Kimby, E
    Coiffier, B
    Brunet, S
    Sanz, MA
    Besalduch, J
    Caballero, D
    Juliusson, G
    Conde, E
    del Potro, E
    Schmitz, N
    BLOOD, 2001, 98 (11) : 482A - 482A
  • [2] Unmutated VH gene status retains its adverse prognostic influence after autologous stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL).
    Lange, A
    Ritgen, M
    Brüggemann, M
    Schmitz, N
    Kneba, M
    Dreger, P
    BLOOD, 2001, 98 (11) : 861A - 861A
  • [3] Prognostic relevance of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL)
    D'Arena, G.
    Napolitano, M.
    Marcacci, G.
    Russo, F.
    Vigliotti, M. L.
    Mauro, F.
    Corazzelli, G.
    Frigeri, F.
    Della Cioppa, P.
    Svanera, G.
    Capobianco, G.
    Nasuti, A.
    Villani, O.
    Pinto, A.
    CYTOMETRY PART A, 2006, 69A (05) : 449 - 449
  • [4] Hematopoietic stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL).
    Horowitz, MM
    Montserrat, E
    Sobocinski, K
    Giralt, S
    Khouri, IF
    Schmitz, N
    BLOOD, 2000, 96 (11) : 522A - 522A
  • [5] Correlation of CD38 expression and cytogenetic abnormalities in chronic lymphocytic leukemia (CLL).
    Abbasi, SY
    Mavromatis, BH
    Ozdemirli, M
    Hartmann, DP
    Cohen, P
    Cheson, BD
    BLOOD, 2003, 102 (11) : 350B - 350B
  • [6] CD38 Expression and Variation as a Prognostic Factor Chronic Lymphocytic Leukemia
    Falay, Mesude
    Ceran, Funda
    Gunes, Ahmet K.
    Dagdas, Simten
    Ayli, Meltem
    Ozet, Gulsum
    CLINICAL LABORATORY, 2016, 62 (07) : 1287 - 1293
  • [7] Analysis of prognostic factors on the outcome of autologous and allogeneic stem cell transplantations (SCT) for chronic lymphocytic leukemia (CLL).
    Michallet, M
    Brand, R
    Dreger, P
    Millighan, D
    Esteve, J
    Kimby, E
    Nicolini, F
    Apperley, J
    van Biezen, A
    Niederwieser, D
    BLOOD, 2001, 98 (11) : 859A - 860A
  • [8] MRD kinetics can predict the time to relapse after autologous stem cell transplantation (SCT) in chronic lymphocytic leukemia (CLL).
    Ritgen, M
    Boettcher, S
    Stilgenbauer, S
    Dohner, H
    Brueggeman, M
    Pott, C
    Raff, T
    Schmitz, N
    Hallek, M
    Kneba, M
    Dreger, P
    BLOOD, 2005, 106 (11) : 211A - 212A
  • [9] CD38 and CD138 expression in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Kampalath, B
    Novoa-Takara, L
    Rao, N
    Shidham, VB
    Chang, CC
    MODERN PATHOLOGY, 2003, 16 (01) : 238A - 238A
  • [10] CD38 and CD138 expression in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Kampalath, B
    Novoa-Takara, L
    Rao, N
    Shidham, VB
    Chang, CC
    LABORATORY INVESTIGATION, 2003, 83 (01) : 238A - 238A